However, inhibiting the kinase activity of RIPK1, which normally activate RIP3, only attenuates alcohol-induced hepatic inflammation but does not offer protection against steatosis and liver injury resulting from chronic ethanol consumption (Wang et al, 2016). Here, RIPK3 is linked to steatosis.